When myeloma returns
When myeloma returns, it is called disease progression, or relapse or recurrence. You and your doctor will need to consider what treatment is needed to try to regain control of the disease.
While options for managing disease progression may have been considered in the initial treatment plan, many doctors like to discuss all the options again. This is because the risks and benefits of treatment are not as clear in people whose myeloma has relapsed, and your views and the disease characteristics may have changed.
In some people, the original treatment can be repeated successfully, especially if the initial response to the treatment was good. In other people, the myeloma may not respond to the treatment that was used previously. This is called resistant or refractory disease.
Treatment options for resistant disease may include:
- taking the same or a different combination of drugs
- having another stem cell transplant
- participating in a clinical trial to access new drugs being developed and tested.
|New treatments are being developed all the time, so if the myeloma comes back, talk to your doctor about what treatments options are available.|
Dr Jane Estell, Senior Staff Specialist, Haematology Department, Concord Cancer Centre, and Senior Clinical Lecturer, The University of Sydney; Brenda Clasquin, 13 11 20 Consultant, Cancer Council NSW; Jacqui Keogh, Senior Myeloma Support Nurse, Myeloma Australia; Dr Silvia Ling, Haematologist, Liverpool Hospital and Sydney Adventist Hospital; and John Miller, Consumer.
View the Cancer Council NSW editorial policy.
The information on this page is also available for download.